Edition:
United Kingdom

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

0.55USD
18 May 2018
Change (% chg)

$0.00 (+0.60%)
Prev Close
$0.55
Open
$0.57
Day's High
$0.57
Day's Low
$0.54
Volume
211,056
Avg. Vol
353,160
52-wk High
$2.27
52-wk Low
$0.47

Chart for

About

Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $263.85
Shares Outstanding(Mil.): 163.88
Dividend: --
Yield (%): --

Financials

  CRIS.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -0.50 -- --
ROI: -124.16 1.57 14.38
ROE: -250.87 2.43 16.07

BRIEF-Curis Files For Mixed Shelf Of Upto $200 Mln

* CURIS INC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING Source text: (https://bit.ly/2rkihf5) Further company coverage:

03 May 2018

BRIEF-Curis Reports Q1 Loss Per Share $0.07

* Q1 EARNINGS PER SHARE VIEW $-0.09 -- THOMSON REUTERS I/B/E/S

03 May 2018

BRIEF-Curis Q4 Loss Per Share $0.05

* CURIS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS

08 Mar 2018

Earnings vs. Estimates